Skip to main content

conjugated estrogens/bazedoxifene 20 mg/1 / .45 mg/1 Medicare Part D Coverage

Brand name: Duavee
Dosage form
TABLET, FILM COATED
Route
ORAL
65%
of Medicare Part D plans
cover conjugated estrogens/bazedoxifene
3,614 of 5,530 plans
3.9
Avg. formulary tier
$44.00
Median 30-day copay
$0.00–$88.00
Copay range

Formulary Tier Distribution

How Medicare Part D plans classify conjugated estrogens/bazedoxifene. Lower tiers = lower copays.

Tier 1 - Preferred Generic 1%
51 plans • avg $0.00/mo
Tier 2 - Generic 0%
6 plans • avg $7.50/mo
Tier 3 - Preferred Brand 7%
256 plans • avg $28.29/mo
Tier 4 - Non-Preferred Drug 91%
3,301 plans • avg $0.46/mo

Find the cheapest plan for conjugated estrogens/bazedoxifene

Enter your ZIP code to compare every plan in your area side-by-side.

Compare Plans for conjugated estrogens/bazedoxifene →

Get conjugated estrogens/bazedoxifene Delivered to Your Door

Compare prices and get discounts from trusted online pharmacies

DrugCovered may earn commissions from pharmacy purchases. Prices and availability vary. Always consult your doctor before starting or changing medications.

conjugated estrogens/bazedoxifene Medicare Coverage by State

Coverage rates and average costs vary significantly by state. Click a state to see the specific plans available there.

Frequently Asked Questions about conjugated estrogens/bazedoxifene

65% of Medicare Part D plans cover conjugated estrogens/bazedoxifene. It is most commonly placed on Tier 4. Coverage varies by plan and geographic area.

The median 30-day copay for conjugated estrogens/bazedoxifene on Medicare Part D is $44.00 at a preferred pharmacy. Costs range from $0.00 to $88.00 depending on the plan.

conjugated estrogens/bazedoxifene is placed on Tier 4 by most Medicare Part D plans. Lower tier numbers generally mean lower copays.

0% of plans require prior authorization for conjugated estrogens/bazedoxifene. Prior authorization means your doctor must confirm the drug is medically necessary before the plan will cover it.

Coverage statistics based on CMS formulary data for plan year 2026. Data updated regularly. Methodology →